Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 9—September 2003
Research

Epidemic and Nonepidemic Multidrug-Resistant Enterococcus faecium

On This Page
Materials and Methods
Results
Discussion
Cite This Article
Figures
Figure 1
Figure 2
Figure 3
Tables
Table 1
Table 2
Downloads
Article
RIS [TXT - 2 KB]
Article Metrics
Metric Details
109
citations of this article
EID Journal Metrics on Scopus
Author affiliations: *University Medical Center Utrecht, Utrecht, the Netherlands; †National Institute of Public Health and the Environment (RIVM), Bilthoven, the Netherlands

Cite This Article

Abstract

The epidemiology of vancomycin-resistant Enterococcus faecium (VREF) in Europe is characterized by a large community reservoir. In contrast, nosocomial outbreaks and infections (without a community reservoir) characterize VREF in the United States. Previous studies demonstrated host-specific genogroups and a distinct genetic lineage of VREF associated with hospital outbreaks, characterized by the variant esp-gene and a specific allele-type of the purK housekeeping gene (purK1). We investigated the genetic relatedness of vanA VREF (n=108) and vancomycin-susceptible E. faecium (VSEF) (n=92) from different epidemiologic sources by genotyping, susceptibility testing for ampicillin, sequencing of purK1, and testing for presence of esp. Clusters of VSEF fit well into previously described VREF genogroups, and strong associations were found between VSEF and VREF isolates with resistance to ampicillin, presence of esp, and purK1. Genotypes characterized by presence of esp, purK1, and ampicillin resistance were most frequent among outbreak-associated isolates and almost absent among community surveillance isolates. Vancomycin-resistance was not specifically linked to genogroups. VREF and VSEF from different epidemiologic sources are genetically related; evidence exists for nosocomial selection of a subtype of E. faecium, which has acquired vancomycin-resistance through horizontal transfer.

Enterococcus faecium has become an important nosocomial pathogen, especially in immunocompromised patients, creating serious limitations in treatment options because of cumulative resistance to antimicrobial agents (1). In the United States, the emergence of nosocomial E. faecium infections was characterized by increasing resistance to ampicillin in the 1980s and a rapid increase of vancomycin resistance in the next decade (1,2). The emergence of vancomycin-resistant E. faecium (VREF) in the United States illustrates the transmission capacities of bacteria and the possibility of a postantibiotic era for nosocomial infections in critically ill patients.

The global epidemiology of VREF is not well understood. In the United States, prevalences of colonization and infection are high among hospitalized patients, but a community reservoir of VREF in healthy persons or animals seems to be absent (3,4). In contrast, in Europe, colonization and infection rates within hospitals remain low, although colonization among healthy persons and animals is prevalent (5–10).

Previous studies suggested host-specificity of VREF genogroups (11), and isolates associated with nosocomial outbreaks seemed to be genetically distinct from nonepidemic VREF isolated from humans and animals (12). The differences between epidemic and nonepidemic isolates were based on genetic relatedness, as determined by amplified fragment length polymorphism analysis (AFLP), and the presence of an identical sequence of the purK housekeeping gene in epidemic strains (12). A recently developed multilocus sequence typing scheme for E. faecium confirmed that epidemic isolates belonged to a specific genetic lineage (13). Moreover, a variant of the esp gene, which has been found to be more prevalent among isolates of E. faecalis associated with infections (14), was found in all but one epidemic hospital-derived VREF isolate and not among community-derived VREF (12). Subsequently, other investigators described the variant esp gene in vancomycin-susceptible E. faecium (VSEF), and this gene appeared to be predominantly present among clinical isolates (15–18).These findings suggest the existence of a specific subpopulation of E. faecium, comprising both VREF as well as VSEF, associated with hospital outbreaks and infections.

In this study, we further investigated the genetic relationship between VREF and VSEF isolates, derived from different epidemiologic sources, such as hospital outbreaks, infections, and colonization among hospitalized patients and healthy persons. The genetic relatedness was linked to the presence of the variant esp gene and antibiotic resistance to ampicillin and vancomycin. On the basis of our findings, we constructed an evolutionary scheme describing the sequential steps in the development and selection of ampicillin- and vancomycin-resistant E. faecium strains.

Materials and Methods

Bacterial Strains and Growth Conditions

Isolates of VREF (n=108) were collected from nosocomial epidemics (n=16), clinical infections (n=20), clinical surveys (n=36), and community surveys (n=36) (Table 1). The genotypes of these isolates have been described previously (11,12). Strains were considered epidemic if they were isolated from patients treated in the same hospital, in the same ward and with an overlapping time-relationship, and if AFLP patterns showed at least 90% similarity (12). Epidemic isolates were recovered from clinical sites, blood and urine, as well as from feces. Only one representative isolate from each outbreak was used for analysis. The number of patients involved in each outbreak varied from 4 to >50 (12,19–23). Isolates were considered to be derived from a clinical infection if obtained from a clinical specimen, such as the blood, urine and wounds. All surveillance isolates, from patients and healthy persons, were isolated from fecal samples. Surveillance isolates were either from the community or from clinical surveillance when obtained from hospitalized patients. The hospital-stay duration of these patients, when cultures were obtained, was not available.

Isolates of VSEF (n=92) were derived from clinical infections (n=73), clinical surveys (n=5), and community surveys (n=14). The isolates from clinical infectious sites were obtained from the SENTRY Antimicrobial Surveillance Program, and originated from different hospitals in several European countries (Portugal, Germany, United Kingdom, France, Spain, Italy, Austria, Turkey, Switzerland, Greece, and Poland). Fifty-seven strains were blood isolates, 5 were isolated from urine, 8 from wounds, and 2 from respiratory tract specimens. Patient information was not available. All VSEF isolates derived from clinical surveys of fecal samples were from the University Hospital Maastricht. All VSEF isolates from community surveys of fecal samples were collected in the Netherlands. All bacterial isolates were collected during the 1990s.

Identification and Susceptibility Testing

Enterococci were identified to the species level and were tested for the presence of the vanA gene by using a multiplex PCR described by Dutka-Malen et al. (24). Vancomycin and ampicillin/amoxicillin susceptibilities were determined by standard agar dilution methods, according to the National Committee for Clinical Laboratory Standards (NCCLS) guidelines (25). We considered MICs >16 μg/mL for ampicillin or amoxicillin and >8 for vancomycin to be resistant.

Esp PCR

All strains were screened for esp by PCR, with two different primer sets (esp 11 [5′-TTGCTAATGCTAGTCCACGACC-3′] to esp 12 [5′-GCGTCAACACTTGCATTGCCGAA-3′] and 14F [5′-AGATTTCATCTTTGATTCTTGG-3′] to 12R [5′-AATTGATTCTTTAGCATCTGG-3′]). PCR conditions included an initial denaturation at 95°C for 15 min for activation of the HotStarTaq DNA polymerase (QIAGEN GmbH, Hilden, Germany), followed by 30 cycles of 94°C for 30 sec, 52°C for 30 sec, and 72°C for 1 min, followed by an extension at 72°C for 7 min. Reactions were performed in 25 μL by using the HotStarTaq Master Mix (QIAGEN GmbH). Strains negative in PCR were checked for the presence of the esp gene by Southern hybridization, as described previously (12). For this check, we generated an esp-specific probe (956 bp) using primers esp 11 and esp 12 (see above).

Sequencing PurK

The purK gene encodes a phosphoribosylaminoimidazole carboxylase ATPase subunit involved in purine biosynthesis and is one of the seven housekeeping genes selected for multilocus sequence typing of E. faecium (13). A 492-bp fragment of the purK gene of a selection of strains, divided over all genogroups, was sequenced by using primers 5′-GCAGATTGGCACATTGAAAGT-3′ and 5′-TACATAAATCCCGCCTGTTTC/T-3′. PCR conditions included an initial denaturation at 95°C for 3 min, followed by 35 cycles of 94°C for 30 sec, 50°C for 30 sec, and 72°C for 30 sec, followed by an extension at 72°C for 5 min. Reactions were performed in 50 μL by using buffers and Taq polymerase (SphaeroQ, Leiden, Netherlands). The PCR products were purified with a PCR purification kit (QIAGEN GmbH) according to the manufacturer’s instructions. Subsequently, purified PCR products were sequenced directly with the ABI PRISM Big Dye Terminators cycle sequencing kit on an ABI PRISM DNA analyzer (Applied Biosystems, Foster City, CA). Sequences were aligned with BioNumerics (v. 2.5, Applied Maths, Kortrijk, Belgium) software.

AFLP

AFLP typing and computer analysis of AFLP-generated patterns of VSEF was done as described previously (11) with minor modifications. Briefly, chromosomal DNA was digested with CfoI and EcoRI and ligated to a single adapter with CfoI and EcoRI protruding ends in a simultaneous reaction, followed by PCR using adapter-specific primers. The amplification products were separated and detected by using POP6-polymer on an ABI PRISM 3700 DNA Analyzer (Applied Biosystems). For each sample, 1 μL of the PCR reaction mixture (8 x diluted) was added to 9 μL of Hi-Di Formamid containing 12.5 μL/mL of the internal size marker (GeneScan-500–labeled with the red fluorescent dye 6-carboxy-x-rhodamine) in a MicroAmp Optical 96-well reaction plate (Applied Biosystems). The analyses were run in 3 hours. Genescan software (Applied Biosystems) was used for collection of data during the analysis and the data were subsequently exported into BioNumerics (Applied Maths) for further analysis. The Pearson product moment correlation coefficient was calculated, and the unweighted pair group method with arithmetic averages was used for cluster analysis. Using this methodology, we described four genogroups of VREF (11). We analyzed all isolates of VSEF and defined a cluster of isolates as a set of individual strains with AFLP patterns that shared at least 65% of the banding patterns (criterion defined for four genogroups [11]). Subsequently, to determine the matching genogroup, we compared AFLP banding patterns of each individual VSEF isolate with AFLP banding patterns of a library of 404 VREF, representing the four different AFLP genogroups. The library included VREF recovered from pigs (n=108) and nonhospitalized persons (n=28) as representatives of genogroup A, and strains from poultry (n=32), hospitalized patients (n=196), and calves (n=40), representing genogroups B, C, and D, respectively (11,12).

VSEF isolates were identified by using the identification module in BioNumerics. The genetic distance used for further analysis is 100 minus the calculated Pearson product moment correlation similarity coefficient. The degree of matching was expressed by an identification factor, which is the quotient of the average genetic distance between the tested strain and each of the isolates in the genogroup divided by the average genetic distance within a genogroup. If the average distance of the tested strain to each of the genogroup members is almost equal to the average distance among all strains in a genogroup, the identification factor will approach the value of one. So the lower the value of the identification factor, the more likely the test strain belongs to a particular genogroup.

Results

Figure 1

Thumbnail of Cluster analysis of vancomycin-susceptible Enterococcus faecium (VSEF) isolates originating from clinical infections and clinical and community surveys. VSEF (n=92) were genotyped by amplified fragment length polymorphism (AFLP). Grouping of AFLP patterns showed four different clusters with >65% similarity. Numbers on the horizontal axis indicate percentage similarity. Closed circles indicate presence of the esp gene and the purK-1 allele and also the source of the isolates. Open

Figure 1. Cluster analysis of vancomycin-susceptible Enterococcus faecium (VSEF) isolates originating from clinical infections and clinical and community surveys. VSEF (n=92) were genotyped by amplified fragment length polymorphism (AFLP). Grouping of AFLP patterns...

Using our predefined cutoff points for cluster analysis, we identified four clusters of VSEF (Figure 1). VSEF clustering seemed to be source-related. Clusters 1 (n=4) and 2 (n=12) contained surveillance isolates from community sources predominantly. All but one of the clinical infections isolates belonged to clusters 3 (n=66) and 4 (n=10), respectively.

On the basis of our calculations of the identification factors of VSEF and representative isolates of different VREF genogroups, we found that isolates of cluster 1 (n=4) resembled those of genogroup A, previously allocated to nonhospitalized patients and pig-derived VREF (Table 2). Similarly, isolates of cluster 2 (n=12) fitted best in genogroup B. Isolates from cluster 3 (n=66) showed almost equal resemblance to isolates from genogroups B and C, and isolates from cluster 4 (n=10) were also most identical to isolates from genogroup C (Table 2). The relationship between AFLP clusters of VSEF and sources was congruent with the previously described clustering of VREF. Almost all VSEF isolates (99%) derived from clinical infections clustered in clusters 3 and 4, clearly distinct from most VSEF isolates from community surveys (93%), which were found in clusters 1 and 2. A similar distribution was found previously among VREF with most (60%) isolates from clinical infections in genogroup C and most (89%) isolates from community surveys in genogroup A (11).

Figure 2

Thumbnail of Frequencies of the esp gene and ampicillin resistance among vancomycin-susceptible enterococci (VSE) and vancomycin-resistant enterococci (VRE) of different origin. Percentages of esp-positive (solid bars) and ampicillin-resistant (dotted bars) VRE and VSE isolates originating from four different sources have been indicated. Clin-Inf, clinical infectious; Clin-Surv, clinical survey; Comm-Surv, community survey.

Figure 2. Frequencies of the esp gene and ampicillin resistance among vancomycin-susceptible enterococci (VSE) and vancomycin-resistant enterococci (VRE) of different origin. Percentages of esp-positive (solid bars) and ampicillin-resistant (dotted bars) VRE and VSE...

The presence of the variant esp gene in VREF and VSEF was strongly associated with a specific epidemiologic source because the presence of esp is higher in clinical infections and epidemic-associated isolates than in surveillance isolates (Figure 2). VREF isolates associated with nosocomial outbreaks were esp-positive, except for one. Prevalences of the variant esp gene in clinical infectious isolates were 57% and 40% for VSEF and VREF, respectively (p=ns). Prevalence of the variant esp gene in clinical and community survey isolates was low among VREF (6% and 3%, respectively) and completely absent among the 19 VSEF isolates tested.

Associations similar to the variant esp gene were found between ampicillin resistance and epidemiologic source for enterococcal isolates (Figure 2). All isolated associated with nosocomial VREF-outbreaks but one were resistant to ampicillin, as were 81% and 65% of infectious isolates of VSEF and VREF, respectively. Thirty-one percent of 36 nosocomial surveillance isolates of VREF were ampicillin resistant, as compared to none of five VSEF isolates obtained by clinical surveillance (p=ns). Finally, all but one isolate of VREF (n=36) and all VSEF isolates (n=14) obtained by surveillance of healthy persons were susceptible to ampicillin. When we combined these data, we found strong associations between the presence of the variant esp-gene and ampicillin resistance, both in VREF and VSEF: 98% of esp-positive VSEF and 92% of esp-positive VREF were resistant to ampicillin, as compared to 37% esp-negative VSEF and 20% esp-negative VREF isolates (p<0.0001).

The purK housekeeping gene was sequenced in 103 isolates: 64 VREF and 39 VSEF. The previously described type 1 allele was found in 39 isolates: 23 VREF and 16 VSEF. This specific allele type was associated with the presence of the variant esp-gene and ampicillin resistance but not with vancomycin resistance. The variant esp-gene was found in 25 (64%) of 39 isolates containing the purK type 1 allele and in only 1 (2%) of 64 isolates carrying other purK alleles (p<0.0001). Similarly, ampicillin resistance was detected in 36 (92%) of 39 isolates with purK type 1 allele and in only 5 (8%) of 64 isolates with other allele types (p<0.0001). In contrast, the vanA transposon was present in 23 (59%) of 39 isolates with purK type 1 allele and in 41 (64%) of 64 isolates with other allele types (p=ns).

Discussion

Our study demonstrates the genetic relatedness of clusters of isolates of vancomycin-resistant and -susceptible E. faecium strains from different epidemiologic sources and provides evidence for selection of an E. faecium subtype associated with hospital outbreaks. This subtype is characterized by the presence of both ampicillin resistance and the variant esp gene. Furthermore, our findings suggest random horizontal spread of the vanA transposon to multiple genogroups of E. faecium. We hypothesize that the rise in infections caused by VREF resulted from nosocomial selection of a specific ampicillin-resistant E. faecium genotype harboring the variant esp gene and subsequent horizontal transfer of the vanA transposon.

Our study confirms that the previously demonstrated dichotomy between VREF isolated from healthy persons and patients (11) also exists for vancomcyin-susceptible E. faecium isolates. In VREF isolates, we could identify four genogroups, which were associated with particular hosts and environments and in which most isolates from healthy persons clustered distinctly from patient isolates. We showed that vancomycin-susceptible isolates clustered into three of these groups and that VSEF isolates from healthy persons also clustered distinctly from patient isolates. The genetic relationship between isolates and the genetic distinction between the four genogroups were based on AFLP analysis. We recently confirmed these findings with multilocus sequence typing (MLST) (13). Other researchers have also demonstrated host specificity of E. faecium. Quednau et al. suggested host specificity of isolates from chicken, pork, and humans by comparing restriction endonuclease profiles (26). In contrast, a recent study by Vancanneyt et al. also used AFLP; they did not confirm host-specific clustering of E. faecium (27). They described two main genomic groups in a population of 78 E. faecium strains isolated from seven European countries, and both groups comprised strains from (healthy) humans, animals, and food. All human clinical strains clustered in the largest genogroup, as did all strains (n=16) containing the vanA gene. Our findings that the vanA transposon was present in isolates of all genogroups proves that acquisition of this transposon was not influenced by and did not affect the preexisting relationship between the bacterium and host, which is a result of a long-term coevolution and mutual adaptation.

The presence of four genogroups in E. faecium seems to parallel the phylogenetic structure in E. coli, in which four ancestral groups (A, B1, B2, and D) have been described with some level of host specificity (28). However, in contrast to our finding of a single genetic lineage in E. faecium related to clinical symptoms and carrying the esp virulence gene, clinical isolates of E. coli are more widely distributed among the different ancestral groups (29). Furthermore, MLST of pathogenic E. coli strains showed that different ancestral lineages have acquired the same virulence factors (30), indicating that pathogenic potential in E. coli is not confined to a single ancestral lineage, which is suggested by our findings for E. faecium. Human and animal pathogenic E. coli strains share closely related genotypes and carry similar virulence factor profiles, suggesting that certain E. coli strains are pathogenic for both animals and humans (31). Whether this holds true for pathogenic E. faecium strains is unknown.

We recently found that the presence of the variant esp-gene is associated with nosocomial outbreaks of VREF in three continents, although this gene was not found in VREF strains isolated from healthy persons or animals (12). The outbreak strains were also characterized by a specific allele type of the purK gene, one of the housekeeping genes sequenced in the MLST method (13). Recently, other investigators reported the presence of the variant esp gene in clinical isolates of VSEF, demonstrating that this gene is not linked specifically to the vanA transposon (15–18). The findings of our study confirm the strong association between the presence of the esp gene and the relation with hospital outbreaks and clinical infections among patients with VREF as well as VSEF. Although the esp gene is virtually absent among community isolates, the presence of esp among VSEF and VREF from clinical infectious sites apparently unrelated to hospital outbreaks implies that this gene is not exclusively related to epidemic strains. Excluding the outbreak potential of the esp-positive VSEF strains in this and other studies is difficult. Only few outbreaks with VSEF have been documented (32–34). We have investigated and could not demonstrate the presence of the variant esp gene in isolates from one hospital outbreak of ampicillin-resistant E. faecium in Norway (data not shown).

Little is known about the function of the variant esp-gene, although epidemiologic findings support its role as a virulence factor. In E. faecalis, the homologue of this gene encodes for the enterococcal surface protein, and the presence of this gene has been associated with enhanced adherence capacities to uroepithelial surfaces, but not with increased virulence, in a mice model (35). Moreover, in E. faecalis, the esp-gene was highly associated with biofilm-formation capacity (36). Increased adherence capacities and biofilm formation of esp-positive E. faecium strains might explain its association with hospital outbreaks.

Like the variant esp gene, ampicillin resistance was found more frequently in isolates associated with infections and nosocomial outbreaks, both in VSEF and VREF. This source-relationship is probably caused by selective pressure of β-lactam antibiotics that are used extensively in hospitals. Emergence of ampicillin resistance in E. faecium was already demonstrated in the early 1980s and seemed to precede the emergence of vancomycin resistance by 10 years (2). A correlation between high prevalences of the esp gene and antibiotic resistance among E. faecium isolates from hospitalized patients was also reported recently by Coque et al. (17).

Figure 3

Thumbnail of Hypothetical evolutionary scheme for Enterococcus faecium genotypes and phenotypes from an ancestral E. faecium type. Open slices indicate esp-negative, ampicillin-susceptible, and vancomycin-susceptible. Closed slices indicate esp-positive, ampicillin-resistant, and vancomycin-resistant. Numbers indicate the number of strains. Arrows indicate the putative evolutionary direction. Clin-Inf, clinical infectious; Clin-Surv, clinical survey; Comm-Surv, community survey. a, dominant geno

Figure 3. Hypothetical evolutionary scheme for Enterococcus faecium genotypes and phenotypes from an ancestral E. faecium type. Open slices indicate esp-negative, ampicillin-susceptible, and vancomycin-susceptible. Closed slices indicate esp-positive, ampicillin-resistant, and vancomycin-resistant. Numbers indicate...

Considering the sources of isolates, presence of ampicillin and vancomycin resistance, the presence of the variant esp gene, and the type 1 allele of the purK gene, we propose an evolutionary scheme for the specific genogroup of E. faecium associated with nosocomial outbreaks (Figure 3). However, our findings might have been biased by the composition of our collection of isolates and the fact that the purK was sequenced in a subset of all isolates. The esp gene and ampicillin resistance can obviously co-occur in a distinct genetic lineage of E. faecium characterized by the type 1 allele of the purK gene. We propose that E. faecium strains containing the type 1 allele of the purK gene have acquired the esp virulence gene and that this E. faecium genotype (purK­-1, esp-positive) is prominently present among clinical relevant strains and virtually absent among survey isolates. Yet another substantial part of the clinical relevant strains with genotype purK-1 do not carry the esp gene, which emphasizes that other virulence genes of E. faecium apart from esp are involved in the development of infections. Ampicillin resistance was predominantly found among the purK-1 genotype and is almost absent among other E. faecium genotypes. This occurrence of resistance is, presumably, the result of selective antibiotic pressure. Chromosomal linkage of the purK-1 allele, the variant esp gene, and ampicillin resistance could have promoted this selection. Finally, glycopeptide usage in and outside hospitals, both in humans and animals, resulted in the selection of vancomycin-resistant strains in both the purK-1 genotype and the other genotypes. The presence of similar proportions of vancomycin resistance in all genotypes probably reflects horizontal transfer of the vancomycin-resistance transposon. This hypothesis implies the development of a hospital-adapted genogroup of E. faecium, characterized by the type-1 allele of purK, the variant esp-gene and ampicillin resistance, which has spread unnoticed, thereby creating a pool of strains with epidemic potential. Only after becoming vancomycin-resistant has this genogroup become recognized as clinically relevant.

Ms. Leavis worked on this study while a medical intern at the Division of Acute Internal Medicine and Infectious Diseases at University Medical Center, Utrecht, Netherlands, and at the National Institute of Public Health and the Environment (RIVM), Bilthoven, Netherlands. Her research interests include the epidemiology of vancomycin-resistant enterococci and enterococcal pathogenicity mechanisms.

Top

Acknowledgment

We thank N. Bruinsma for vancomycin-susceptible Enterococcus faecium samples.

Top

References

  1. Murray  BE. Vancomycin-resistant enterococcal infections. N Engl J Med. 2000;342:710–21. DOIPubMedGoogle Scholar
  2. Grayson  ML, Eliopoulos  GM, Wennersten  CB, Ruoff  KL, De Girolami  PC, Ferraro  MJ, Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob Agents Chemother. 1991;35:2180–4.PubMedGoogle Scholar
  3. Coque  TM, Tomayko  JF, Ricke  SC, Okhuysen  PC, Murray  BE. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother. 1996;40:2605–9.PubMedGoogle Scholar
  4. Welton  LA, Thal  LA, Perri  MB, Donabedian  S, McMahon  J, Chow  JW, Antimicrobial resistance in enterococci isolated from Turkey flocks fed virginiamycin. Antimicrob Agents Chemother. 1998;42:705–8.PubMedGoogle Scholar
  5. van der Auwera  P, Pensart  N, Korten  V, Murray  BE, Leclercq  R. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis. 1996;173:1129–36.PubMedGoogle Scholar
  6. van Belkun  A, van den Braak  N, Thomassen  R, Verbrugh  H, Endtz  H. Vancomycin-resistant enterococci in cats and dogs. Lancet. 1996;348:1038–9. DOIPubMedGoogle Scholar
  7. Endtz  HP, van den Braak  N, van Belkum  A, Kluytmans  JA, Koeleman  JG, Spanjaard  L, Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in the Netherlands. J Clin Microbiol. 1997;35:3026–31.PubMedGoogle Scholar
  8. Stobberingh  E. van den BA, London N, Driessen C, Top J, Willems R. Enterococci with glycopeptide resistance in turkeys, turkey farmers, turkey slaughterers, and (sub)urban residents in the south of the Netherlands: evidence for transmission of vancomycin resistance from animals to humans? Antimicrob Agents Chemother. 1999;43:2215–21.PubMedGoogle Scholar
  9. van den Bogaard  AE, Mertens  P, London  NH, Stobberingh  EE. High prevalence of colonization with vancomycin- and pristinamycin-resistant enterococci in healthy humans and pigs in the Netherlands: is the addition of antibiotics to animal feeds to blame? J Antimicrob Chemother. 1997;40:454–6. DOIPubMedGoogle Scholar
  10. van den Braak  N, van Belkum  A, van Keulen  M, Vliegenthart  J, Verbrugh  HA, Endtz  HP. Molecular characterization of vancomycin-resistant enterococci from hospitalized patients and poultry products in the Netherlands. J Clin Microbiol. 1998;36:1927–32.PubMedGoogle Scholar
  11. Willems  RJL, Top  J, van den Braak  N, van Belkum  A, Endtz  H, Mevius  D, Host specificity of vancomycin-resistant Enterococcus faecium. J Infect Dis. 2000;182:816–23. DOIPubMedGoogle Scholar
  12. Willems  R, Homan  W, Top  J, van Santen-Verheuvel  M, Tribe  D, Manzioros  X, Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals. Lancet. 2001;357:853–5. DOIPubMedGoogle Scholar
  13. Homan  WL, Tribe  D, Poznanski  S, Li  M, Hogg  G, Spalburg  E, Multilocus sequence typing scheme for Enterococcus faecium. J Clin Microbiol. 2002;40:1963–71. DOIPubMedGoogle Scholar
  14. Shankar  V, Baghdayan  AS, Huycke  MM, Lindahl  G, Gilmore  MS. Infection-derived Enterococcua faecalis strains are enriched in esp, a gene encoding a novel surface protein. Infect Immun. 1999;67:193–200.PubMedGoogle Scholar
  15. Woodford  N, Soltani  M, Hardy  KJ. Frequency of esp in Enterococcus faecium isolates. Lancet. 2001;358:584. DOIPubMedGoogle Scholar
  16. Baldassarri  L, Bertuccini  L, Ammendolia  MG, Gherardi  G, Creti  R. Variant esp gene in vancomycin-sensitive Enterococcus faecium. Lancet. 2001;357:1802. DOIPubMedGoogle Scholar
  17. Coque  TM, Willems  R, Canton  R, Del Campo  R, Baquero  F. High occurrence of esp among ampicillin-resistant and vancomycin-susceptible Enterococcus faecium clones from hospitalized patients. J Antimicrob Chemother. 2002;50:1035–8. DOIPubMedGoogle Scholar
  18. Rice  LB, Carias  L, Rudin  S, Vael  C, Goossens  H, Konstabel  C, A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin. J Infect Dis. 2003;187:508–12. DOIPubMedGoogle Scholar
  19. Jordens  JZ, Bates  J, Griffiths  DT. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother. 1994;34:515–28. DOIPubMedGoogle Scholar
  20. Timmers  GJ, van der Zwet  WC, Simoons-Smit  IM, Savelkoul  PH, Meester  HH, Vandenbroucke-Grauls  CM, Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: risk factor assessment and successful control of the epidemic. Br J Haematol. 2002;116:826–33. DOIPubMedGoogle Scholar
  21. Bonten  M, Hayden  MK, Nathan  C, van Voorhis  J, Matushek  M, Slaughter  S, Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet. 1996;348:1615–9. DOIPubMedGoogle Scholar
  22. Bonten  MJM, Hayden  MK, Nathan  C, Rice  TW, Weinstein  RA. Stability of vancomycin-resistant enterococcal genotypes isolated from long-term-colonized patients. J Infect Dis. 1998;177:378–82. DOIPubMedGoogle Scholar
  23. Dunne  WM, Wang  W. Clonal dissemination and colony morphotype variation of vancomycin-resistant Enterococcus faecium isolates in metropolitan Detroit, Michigan. J Clin Microbiol. 1997;35:388–92.PubMedGoogle Scholar
  24. Dutka-Malen  S, Evers  S, Courvalin  P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol. 1995;33:24–7.PubMedGoogle Scholar
  25. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standards M7-A5. Wayne (PA): The Committee; 2001.
  26. Quednau  M, Ahrne  S, Molin  G. Genomic relationships between Enterococcus faecium strains from different sources and with different antibiotic resistance profiles evaluated by restriction endonuclease analysis of total chromosomal DNA using EcoRI and PvuII. Appl Environ Microbiol. 1999;65:1777–80.PubMedGoogle Scholar
  27. Vancanneyt  M, Lombardi  A, Andrighetto  C, Knijff  E, Torriani  S, Bjorkroth  KJ, Intraspecies genomic groups in Enterococcus faecium and their correlation with origin and pathogenicity. Appl Environ Microbiol. 2002;68:1381–91. DOIPubMedGoogle Scholar
  28. Herzer  PJ, Inouye  S, Inouye  M, Whittam  TS. Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J Bacteriol. 1990;172:6175–81.PubMedGoogle Scholar
  29. Rolland  K, Lambert-Zechovsky  N, Picard  B, Denamur  E. Shigella and enteroinvasive Escherichia coli strains are derived from distinct ancestral strains of E. coli. Microbiology. 1998;144:2667–72. DOIPubMedGoogle Scholar
  30. Reid  SD, Herbelin  CJ, Bumbaugh  AC, Selander  RK, Whittam  TS. Parallel evolution of virulence in pathogenic Escherichia coli. Nature. 2000;406:64–7. DOIPubMedGoogle Scholar
  31. Johnson  JR, Delavari  P, Stell  AL, Whittam  TS, Carlino  U, Russo  TA. Molecular comparison of extraintestinal Escherichia coli isolates of the same electrophoretic lineages from humans and domestic animals. J Infect Dis. 2001;183:154–9. DOIPubMedGoogle Scholar
  32. Suppola  JP, Kolho  E, Salmenlinna  S, Tarkka  E, Vuopio-Varkila  J, Vaara  M. vanA and vanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain: effect on interpretation of clonality. J Clin Microbiol. 1999;37:3934–9.PubMedGoogle Scholar
  33. Mohn  SC, Harthug  S, Langeland  N. Outbreak of ampicillin-resistant Enterococcus faecium—risk factors for faecal colonisation. APMIS. 2000;108:296–302. DOIPubMedGoogle Scholar
  34. Torell  E, Cars  O, Hambraeus  A. Ampicillin-resistant enterococci in a Swedish university hospital: nosocomial spread and risk factors for infection. Scand J Infect Dis. 2001;33:182–7. DOIPubMedGoogle Scholar
  35. Shankar  N, Lockatell  CV, Baghdayan  AS, Drachenberg  C, Gilmore  MS, Johnson  DE. Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection. Infect Immun. 2001;69:4366–72. DOIPubMedGoogle Scholar
  36. Toledo-Arana  A, Valle  J, Solano  C, Arrizubieta  MJ, Cucarella  C, Lamata  M, The enterococcal surface protein, Esp, is involved in Enterococcus faecalis biofilm formation. Appl Environ Microbiol. 2001;67:4538–45. DOIPubMedGoogle Scholar

Top

Figures
Tables

Top

Cite This Article

DOI: 10.3201/eid0909.020383

Table of Contents – Volume 9, Number 9—September 2003

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

M.J.M. Bonten, Department of Internal Medicine, Division of Acute Internal Medicine and Infectious Diseases, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands; fax: +31 30 2523741

Send To

10000 character(s) remaining.

Top

Page created: December 30, 2010
Page updated: December 30, 2010
Page reviewed: December 30, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external